Skip to main content

What the FDA labels say about taking them together

Daunorubicin and methotrexate

Daunorubicin's FDA label of January 19, 2026 names methotrexate in its drug interactions section; the methotrexate labels PlainMeds reads (4) do not name daunorubicin. The daunorubicin label: “Hepatotoxic medications, such as high-dose methotrexate, may impair liver function and increase the risk of toxicity.”

Check it at the source: the daunorubicin FDA label on DailyMed (effective January 19, 2026, Hisun Pharmaceuticals USA, Inc.); the methotrexate FDA label on DailyMed (effective May 27, 2026, Accord Healthcare Inc.).

What does the daunorubicin label say about methotrexate?

Daunorubicin label, drug interactions

Hepatotoxic medications, such as high-dose methotrexate, may impair liver function and increase the risk of toxicity.

Source: FDA drug label (Daunorubicin Hydrochloride), Hisun Pharmaceuticals USA, Inc., effective January 19, 2026 (SPL set 9705fa12-499e-41a3-8fb4-f6df0858b851), via openFDA; the full label on DailyMed

What does the methotrexate label say about daunorubicin?

Methotrexate's label (effective May 27, 2026) and its 3 other brand-application labels do not name daunorubicin in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Methotrexate), Accord Healthcare Inc., effective May 27, 2026 (SPL set 874c7f43-a3be-4236-89cc-24c44e3c5813), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

2Daunorubicin generic labelers
29Methotrexate generic labelers
DaunorubicinMethotrexate
Labeled forLeukemia, lymphoma and myelomaRheumatoid arthritis, Psoriasis, Leukemia, lymphoma and myeloma, Breast cancer
Boxed warningYesYes
Pharmacy cost (NADAC)n/a$0.158 per tablet 2.5 mg tablet
Shortage nowNo current entryIn shortage

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?